Healthcare ❯ Medical Devices

Regulatory Compliance

FDA Regulations False Claims Act Market Competition Financial Obligations South African Health Products Regulatory Authority Misbranding Product Development FDA Approval Process

DexCom Investors Face Late-December Deadlines in Suits Over FDA-Flagged CGM Changes

Investor law firms set late-December deadlines tied to suits referencing an FDA warning over unauthorized CGM sensor changes.

Exactech to Pay $8 Million After Court Approves False Claims Act Settlement